Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2007
11/14/2007EP1853267A1 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof
11/14/2007EP1853266A1 Methods and compositions for treating diabetes, metabolic syndrome and other conditions
11/14/2007EP1853262A1 Pharmaceutical composition comprising amorphous rosiglitazone
11/14/2007EP1853240A2 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
11/14/2007EP1581223B1 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
11/14/2007EP1495018B1 Tricyclic thrombin receptor antagonists
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007EP1423012B1 Medical use of stem cells expressing vegfr-1
11/14/2007EP1399423B1 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
11/14/2007EP1373503B1 Neurotrophic factors
11/14/2007EP1343903B1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell
11/14/2007EP1286691B1 Methods for treatment of diseases associated with acute inflammation under non-ischemic conditions
11/14/2007EP1235592B1 Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicament
11/14/2007EP1121930B1 Drug preparation "histochrome" for treating acute myocardial infarction and ischaemic heart diseases
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0641218B2 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality
11/14/2007CN101072778A Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy
11/14/2007CN101072769A Antiplatelet agent and process for producing the same
11/14/2007CN101072753A Process for the preparation of carvedilol and its enantiomers
11/14/2007CN101072573A Bacterial compositions for prevention or treatment of atherosclerotic disorders
11/14/2007CN101072562A Use ranolazone in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
11/14/2007CN101072561A Diaminoalkane aspartic protease inhibitors
11/14/2007CN101072557A Use of PPAR agonists for the treatment of congestive heart failure
11/14/2007CN101072509A Treatment and prevention of inflammatory disorders
11/14/2007CN101070546A Human LPL gene mutation body of resisting atheroscleorsis
11/14/2007CN101070338A Tanshinone IIA potassium sulfonate used for preparing medicine for preventing and treating cerebral ischemia and cerebral anoxia and myocardial ischemia and myocardio anoxia
11/14/2007CN101070323A Porphyrin derivative, its preparing method and use of same as small-molecular anti-oxidation agent
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101069742A Pancreatic kininogenase tablet and preparing method
11/14/2007CN101069733A Medicine for treating viral myocarditis and cardiac muscle diseases
11/14/2007CN101069731A Ready-made Chinese medicine jelly-pills for treating hypertension
11/14/2007CN101069721A Medicine for treating heart disease
11/14/2007CN101069718A Selenium-rich tea pigment capsule
11/14/2007CN101069697A Decay eliminating liquid for treating pile
11/14/2007CN101069684A Composition comprising a cholesterol absorption inhibitor, and hmg-coa reductase inhibitor and a stabilizing agent
11/14/2007CN101069571A Pine-pollen-leave drink and preparing method
11/14/2007CN101069560A Jinpuqi cold tea
11/14/2007CN101069559A Ganoderma-lucidum grain lotus-seed-heart powder
11/14/2007CN101069532A Blended oil in which the ratio of linoleic acid and linolenic acid is 4:1
11/14/2007CN100348609C Glucocorticoid receptor ligands for the treatment of metabolic disorders
11/14/2007CN100348598C Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
11/14/2007CN100348587C Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/14/2007CN100348585C Novel method of synthesising 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one derivatives and use thereof in the synthesis of ivabradine and the salts thereof for addition to a pharmaceutically acceptable aci
11/14/2007CN100348584C 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
11/14/2007CN100348583C Novel enantiomer of tetra hydrogen isoquinoline derivative and officinal salt, preparation and pharmaceutical composition thereof
11/14/2007CN100348568C Process for extracting high purity alpha-linolenic acid from pepper category and medicine application thereof
11/14/2007CN100348264C Cinnamon twig decoction drop pill and its preparation method
11/14/2007CN100348233C Preparation method of Chinese medicinal composition for treating allodromy
11/14/2007CN100348232C Arrhythmia treating Chinese medicine composition
11/14/2007CN100348226C Hypertension treating medicine
11/14/2007CN100348223C Medicine for treating ischemic cerebral disease and its prepn
11/14/2007CN100348218C Composition comprising the extract of cistanche deserticola Y.C. ma showing enhancing activity of the neurite outgrowth and neurotrophic effects
11/14/2007CN100348216C Compound injection from ice tablet and Danshen Root extract and its preparation thereof
11/14/2007CN100348214C Large specification vessel freeing drip pill and its preparation method
11/14/2007CN100348211C Health caring product prescription for treating cardiovascular and cerebrovascular disease and its preparation process
11/14/2007CN100348206C Application of speedwell extract in preparing medicine
11/14/2007CN100348200C Medicinal use of paeoniflorin
11/14/2007CN100348198C Monosialic acid tetrahexose ganglioside liposome complex preparation
11/14/2007CN100348195C Compound blood pressure reducing preparation
11/14/2007CN100348182C Method for extracting amino acid from earthworm body using organic substance
11/14/2007CN100348116C Lily tea with health-preserving function
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294629 Drugs as enzyme inhibitors for tyrosine kinases and for treatment of psoriasis
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007US7294618 Glucopyranosyloxypyrazole derivatives and medicinal use thereof
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007US7294345 Otorhinological delivery device
11/13/2007US7294334 Methods and compositions to treat myocardial conditions
11/13/2007CA2425557C Anticholinergic agents that can be used as medicaments and method for the production thereof
11/13/2007CA2345006C New benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmaceutical compositions
11/13/2007CA2231052C Benzoxazepine compounds, their production and use as lipid lowering agents
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2209904C Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/13/2007CA2152137C Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
11/08/2007WO2007127965A1 Treating glaucoma, cardiovascular diseases, and renal diseases
11/08/2007WO2007127475A2 Pyridazines for demyelinating diseases and neuropathic pain
11/08/2007WO2007127377A2 Combinations comprising omega-3 fatty acid compounds for the treatment of cardiovascular disease
11/08/2007WO2007126771A2 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
11/08/2007WO2007126358A1 Diphenylazetidinone derivates possessing cholesterol absor tion inhibitor activit.
11/08/2007WO2007126135A1 Pharmaceutical composition of angiotensin ii antagonists with pioglitazone hcl
11/08/2007WO2007126020A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same
11/08/2007WO2007126017A1 Agent for suppressing arteriosclerosis
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007WO2007125915A1 Solid matter containing coenzyme q
11/08/2007WO2007125720A1 Molecular chaperone expression inducer
11/08/2007WO2007125644A1 Fat absorption inhibitor
11/08/2007WO2007125049A1 Use of cbx cannabinoid receptor modulators as potassium channel modulators
11/08/2007WO2007125048A1 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators
11/08/2007WO2007124854A1 Heterocyclic substituted, anellated pyrazole derivative and its uses
11/08/2007WO2007124674A1 Compositions for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders
1 ... 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 ... 1595